nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—Fesoterodine—ABCB1—adrenal gland cancer	0.0204	1	CrCbGaD
Tolterodine—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00275	0.00281	CbGpPWpGaD
Tolterodine—CHRM4—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00274	0.0028	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00274	0.0028	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00271	0.00277	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00271	0.00277	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00269	0.00274	CbGpPWpGaD
Tolterodine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00266	0.00272	CbGpPWpGaD
Tolterodine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00264	0.0027	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00263	0.00268	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00262	0.00268	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0026	0.00265	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00257	0.00263	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00247	0.00252	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00244	0.00249	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GNRHR—adrenal gland cancer	0.00241	0.00246	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0024	0.00245	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—GNAS—adrenal gland cancer	0.00236	0.00241	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00234	0.00239	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GNRHR—adrenal gland cancer	0.00231	0.00235	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0023	0.00234	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00224	0.00229	CbGpPWpGaD
Tolterodine—CHRM4—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00223	0.00228	CbGpPWpGaD
Tolterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00218	0.00223	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00218	0.00222	CbGpPWpGaD
Tolterodine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00215	0.00219	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00214	0.00219	CbGpPWpGaD
Tolterodine—CHRM5—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00214	0.00218	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SDHB—adrenal gland cancer	0.00212	0.00216	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0021	0.00215	CbGpPWpGaD
Tolterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00209	0.00213	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—TSHR—adrenal gland cancer	0.00208	0.00213	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00202	0.00206	CbGpPWpGaD
Tolterodine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00183	0.00186	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00181	0.00185	CbGpPWpGaD
Tolterodine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00181	0.00185	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00181	0.00184	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00179	0.00183	CbGpPWpGaD
Tolterodine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00174	0.00178	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00166	0.0017	CbGpPWpGaD
Tolterodine—CHRM4—GPCR ligand binding—POMC—adrenal gland cancer	0.00166	0.0017	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—GNAS—adrenal gland cancer	0.00166	0.00169	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00165	0.00168	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00164	0.00168	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00164	0.00168	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00163	0.00166	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00162	0.00166	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GNRHR—adrenal gland cancer	0.00162	0.00165	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00162	0.00165	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00161	0.00164	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.0016	0.00164	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.0016	0.00163	CbGpPWpGaD
Tolterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00159	0.00163	CbGpPWpGaD
Tolterodine—CHRM5—GPCR ligand binding—POMC—adrenal gland cancer	0.00159	0.00162	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00156	0.00159	CbGpPWpGaD
Tolterodine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.00154	0.00157	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00151	0.00154	CbGpPWpGaD
Tolterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00151	0.00154	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.0015	0.00154	CbGpPWpGaD
Tolterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.0015	0.00153	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—PRKACA—adrenal gland cancer	0.0015	0.00153	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00149	0.00152	CbGpPWpGaD
Tolterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.00149	0.00152	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00148	0.00151	CbGpPWpGaD
Tolterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00147	0.0015	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	0.00147	0.0015	CbGpPWpGaD
Tolterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00147	0.0015	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—TSHR—adrenal gland cancer	0.00146	0.00149	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00146	0.00149	CbGpPWpGaD
Tolterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00145	0.00148	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.00145	0.00148	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GNRH1—adrenal gland cancer	0.00144	0.00147	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00142	0.00145	CbGpPWpGaD
Tolterodine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.00142	0.00144	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00141	0.00144	CbGpPWpGaD
Tolterodine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0014	0.00143	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00139	0.00142	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GNRH1—adrenal gland cancer	0.00138	0.00141	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.00138	0.0014	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—RRM1—adrenal gland cancer	0.00136	0.00139	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—SDHD—adrenal gland cancer	0.00136	0.00139	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00135	0.00138	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00134	0.00136	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00132	0.00135	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00132	0.00135	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TSHR—adrenal gland cancer	0.00129	0.00131	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—CDC42—adrenal gland cancer	0.00127	0.0013	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00127	0.00129	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.00127	0.00129	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—SPRY2—adrenal gland cancer	0.00126	0.00129	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.00125	0.00128	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TSHR—adrenal gland cancer	0.00123	0.00126	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—GNAS—adrenal gland cancer	0.00121	0.00124	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—MEN1—adrenal gland cancer	0.00121	0.00123	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—MEN1—adrenal gland cancer	0.00116	0.00118	CbGpPWpGaD
Tolterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00112	0.00115	CbGpPWpGaD
Tolterodine—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Tolterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Tolterodine—CHRM3—GPCR ligand binding—POMC—adrenal gland cancer	0.00112	0.00114	CbGpPWpGaD
Tolterodine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.00111	0.00113	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00108	0.00111	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00105	0.00108	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00105	0.00107	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00104	0.00106	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—MED12—adrenal gland cancer	0.00102	0.00104	CbGpPWpGaD
Tolterodine—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	0.000995	0.00102	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000987	0.00101	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000984	0.001	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000981	0.001	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000973	0.000993	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000971	0.000991	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GNRH1—adrenal gland cancer	0.00097	0.00099	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.00096	0.00098	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00094	0.00096	CbGpPWpGaD
Tolterodine—CHRM4—GPCR downstream signaling—POMC—adrenal gland cancer	0.000939	0.000958	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000937	0.000957	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000928	0.000947	CbGpPWpGaD
Tolterodine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	0.000925	0.000944	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—PRKACA—adrenal gland cancer	0.000923	0.000942	CbGpPWpGaD
Tolterodine—CHRM5—GPCR downstream signaling—POMC—adrenal gland cancer	0.000899	0.000918	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000893	0.000912	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—CDC42—adrenal gland cancer	0.000891	0.000909	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	0.00089	0.000908	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—SPRY2—adrenal gland cancer	0.000887	0.000905	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000886	0.000905	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000886	0.000905	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—PRKACA—adrenal gland cancer	0.000884	0.000902	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000882	0.0009	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000878	0.000896	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	0.000867	0.000885	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TSHR—adrenal gland cancer	0.000864	0.000882	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000856	0.000874	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000854	0.000871	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—POMC—adrenal gland cancer	0.000852	0.00087	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—GNAS—adrenal gland cancer	0.000851	0.000869	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000843	0.00086	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	0.000827	0.000844	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—POMC—adrenal gland cancer	0.000816	0.000833	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000815	0.000832	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000815	0.000832	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	0.000815	0.000832	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—MEN1—adrenal gland cancer	0.000812	0.000829	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000808	0.000825	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000808	0.000825	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000805	0.000821	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CDC42—adrenal gland cancer	0.000783	0.000799	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF2—adrenal gland cancer	0.000754	0.00077	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CDC42—adrenal gland cancer	0.00075	0.000765	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—GNAS—adrenal gland cancer	0.000748	0.000763	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PRKACA—adrenal gland cancer	0.000742	0.000757	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000729	0.000745	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF2—adrenal gland cancer	0.000722	0.000737	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—GNAS—adrenal gland cancer	0.000716	0.000731	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—IGF1R—adrenal gland cancer	0.000698	0.000713	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000661	0.000675	CbGpPWpGaD
Tolterodine—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000633	0.000646	CbGpPWpGaD
Tolterodine—CHRM3—GPCR downstream signaling—POMC—adrenal gland cancer	0.000631	0.000644	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TERT—adrenal gland cancer	0.000628	0.000641	CbGpPWpGaD
Tolterodine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000625	0.000638	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000622	0.000635	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—PRKACA—adrenal gland cancer	0.00062	0.000633	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000614	0.000627	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000608	0.000621	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000603	0.000615	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TERT—adrenal gland cancer	0.000601	0.000614	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—GNAS—adrenal gland cancer	0.000601	0.000614	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000591	0.000603	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—ABCB1—adrenal gland cancer	0.00059	0.000602	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	0.000575	0.000587	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—POMC—adrenal gland cancer	0.000573	0.000585	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000567	0.000579	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—BAD—adrenal gland cancer	0.000546	0.000558	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000539	0.00055	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	0.000533	0.000544	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	0.000533	0.000544	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	0.000528	0.000539	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CDC42—adrenal gland cancer	0.000526	0.000537	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—BAD—adrenal gland cancer	0.000523	0.000534	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000521	0.000532	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	0.000509	0.000519	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF2—adrenal gland cancer	0.000507	0.000518	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	0.000504	0.000515	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—POMC—adrenal gland cancer	0.000504	0.000514	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—GNAS—adrenal gland cancer	0.000503	0.000513	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000502	0.000513	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.000498	0.000508	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—BRAF—adrenal gland cancer	0.000497	0.000508	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000492	0.000502	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—IGF1R—adrenal gland cancer	0.00049	0.0005	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000485	0.000496	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—POMC—adrenal gland cancer	0.000482	0.000492	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.000482	0.000492	CbGpPWpGaD
Tolterodine—CHRM4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000482	0.000492	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—BRAF—adrenal gland cancer	0.000476	0.000486	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000471	0.000481	CbGpPWpGaD
Tolterodine—CHRM5—Signaling by GPCR—EGFR—adrenal gland cancer	0.000462	0.000471	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000443	0.000453	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.00044	0.000449	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.00043	0.000439	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	0.000423	0.000432	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TERT—adrenal gland cancer	0.000422	0.000431	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.000418	0.000427	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—POMC—adrenal gland cancer	0.000405	0.000413	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—MED12—adrenal gland cancer	0.000397	0.000406	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000391	0.000399	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000383	0.000391	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	0.000368	0.000376	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BAD—adrenal gland cancer	0.000367	0.000375	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000364	0.000371	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000359	0.000367	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000359	0.000367	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000356	0.000364	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.000353	0.00036	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.00035	0.000357	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000344	0.000351	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	0.00034	0.000347	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—POMC—adrenal gland cancer	0.000338	0.000345	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	0.000335	0.000342	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000335	0.000342	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—BRAF—adrenal gland cancer	0.000334	0.000341	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000331	0.000338	CbGpPWpGaD
Tolterodine—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000325	0.000332	CbGpPWpGaD
Tolterodine—CHRM3—Signaling by GPCR—EGFR—adrenal gland cancer	0.000324	0.000331	CbGpPWpGaD
Tolterodine—CHRM3—Metabolism—PTGS2—adrenal gland cancer	0.000323	0.00033	CbGpPWpGaD
Tolterodine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.000321	0.000327	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	0.00029	0.000296	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—EGFR—adrenal gland cancer	0.000285	0.000291	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—EGFR—adrenal gland cancer	0.000273	0.000278	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000263	0.000269	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000242	0.000247	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000242	0.000247	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000242	0.000247	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.00024	0.000245	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000239	0.000244	CbGpPWpGaD
Tolterodine—CHRM4—Signaling Pathways—TP53—adrenal gland cancer	0.000239	0.000244	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	0.000235	0.00024	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	0.000231	0.000235	CbGpPWpGaD
Tolterodine—CHRM5—Signaling Pathways—TP53—adrenal gland cancer	0.000229	0.000234	CbGpPWpGaD
Tolterodine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.00021	0.000214	CbGpPWpGaD
Tolterodine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.000193	0.000197	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	0.000192	0.000196	CbGpPWpGaD
Tolterodine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000191	0.000195	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—EGFR—adrenal gland cancer	0.000191	0.000195	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.00019	0.000193	CbGpPWpGaD
Tolterodine—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	0.000161	0.000165	CbGpPWpGaD
Tolterodine—CHRM3—Signaling Pathways—TP53—adrenal gland cancer	0.000161	0.000164	CbGpPWpGaD
Tolterodine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	0.000159	0.000162	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—POMC—adrenal gland cancer	0.000158	0.000162	CbGpPWpGaD
Tolterodine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	0.000126	0.000129	CbGpPWpGaD
